Johnson Matthey (LON:JMAT) Trading Up 27.6% – Still a Buy?

Shares of Johnson Matthey PLC (LON:JMATGet Free Report) traded up 27.6% during trading on Thursday . The company traded as high as GBX 1,888 ($25.56) and last traded at GBX 1,773 ($24.00). 3,584,157 shares were traded during mid-day trading, an increase of 31% from the average session volume of 2,745,484 shares. The stock had previously closed at GBX 1,389 ($18.80).

Johnson Matthey Price Performance

The stock has a market cap of £2.89 billion, a P/E ratio of 29.40, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The business’s fifty day moving average price is GBX 1,307.66 and its 200 day moving average price is GBX 1,377.54.

Johnson Matthey (LON:JMATGet Free Report) last posted its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Sell-side analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.

Johnson Matthey Increases Dividend

The business also recently announced a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were issued a GBX 32 ($0.43) dividend. The ex-dividend date of this dividend was Thursday, April 10th. This represents a dividend yield of 1.88%. This is a boost from Johnson Matthey’s previous dividend of $22.00. Johnson Matthey’s dividend payout ratio is 130.84%.

Insider Transactions at Johnson Matthey

In related news, insider Liam Condon bought 27 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was purchased at an average price of GBX 1,445 ($19.56) per share, with a total value of £390.15 ($528.16). Over the last 90 days, insiders purchased 75 shares of company stock valued at $99,927. 0.61% of the stock is currently owned by insiders.

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.